| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 41899 |
Unlisted procedure, dentoalveolar structures |
378 |
353 |
$1.58M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,103 |
2,614 |
$531K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,821 |
4,113 |
$526K |
| G0378 |
Hospital observation service, per hour |
1,119 |
901 |
$434K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,605 |
699 |
$241K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,207 |
1,947 |
$146K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,326 |
1,058 |
$20K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
633 |
541 |
$18K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
990 |
892 |
$10K |
| 80053 |
Comprehensive metabolic panel |
9,272 |
6,598 |
$9K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
830 |
609 |
$5K |
| 84484 |
|
5,244 |
3,730 |
$5K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,121 |
7,132 |
$3K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
118 |
110 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
106 |
75 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
491 |
459 |
$2K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,703 |
1,542 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
1,604 |
717 |
$1K |
| 81001 |
|
3,384 |
2,939 |
$937.18 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
262 |
235 |
$870.35 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,398 |
1,763 |
$867.37 |
| 71045 |
Radiologic examination, chest; single view |
4,089 |
3,459 |
$692.42 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
888 |
816 |
$681.27 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,469 |
4,313 |
$675.42 |
| 87040 |
|
169 |
146 |
$540.82 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
270 |
257 |
$361.34 |
| 73562 |
|
51 |
50 |
$331.76 |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
137 |
123 |
$323.42 |
| 83690 |
|
1,968 |
1,628 |
$323.38 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,268 |
1,460 |
$315.04 |
| 83735 |
|
4,723 |
3,242 |
$309.09 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,519 |
939 |
$308.54 |
| 87581 |
|
108 |
99 |
$270.46 |
| 93971 |
|
12 |
12 |
$222.59 |
| 82550 |
|
3,325 |
2,541 |
$212.61 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,128 |
976 |
$176.93 |
| 82553 |
|
1,120 |
983 |
$167.49 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
244 |
166 |
$121.86 |
| 83605 |
|
702 |
605 |
$86.80 |
| 84443 |
Thyroid stimulating hormone (TSH) |
371 |
322 |
$76.13 |
| 85379 |
|
315 |
302 |
$72.95 |
| J3490 |
Unclassified drugs |
500 |
281 |
$59.36 |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
61 |
57 |
$48.79 |
| 85730 |
|
1,468 |
1,340 |
$41.53 |
| 94664 |
|
239 |
136 |
$36.52 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
565 |
471 |
$29.53 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
118 |
110 |
$23.19 |
| 87070 |
|
39 |
36 |
$22.86 |
| 85610 |
|
2,186 |
1,932 |
$22.37 |
| 83880 |
|
709 |
619 |
$16.32 |
| 87428 |
|
35 |
34 |
$6.50 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
712 |
626 |
$4.30 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
127 |
113 |
$4.12 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
296 |
269 |
$0.66 |
| J7050 |
Infusion, normal saline solution, 250 cc |
459 |
284 |
$0.46 |
| 84100 |
|
701 |
475 |
$0.26 |
| 87107 |
|
187 |
175 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
444 |
358 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
107 |
85 |
$0.00 |
| 97161 |
|
13 |
13 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
101 |
45 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
388 |
304 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
18 |
14 |
$0.00 |
| 85007 |
|
16 |
14 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
17 |
14 |
$0.00 |
| 71250 |
|
12 |
12 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
44 |
24 |
$0.00 |
| 84439 |
|
15 |
15 |
$0.00 |
| 87186 |
|
26 |
25 |
$0.00 |
| 86850 |
|
13 |
12 |
$0.00 |
| 94760 |
|
388 |
216 |
$0.00 |
| 87077 |
|
208 |
196 |
$0.00 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
84 |
76 |
$0.00 |
| G0379 |
Direct admission of patient for hospital observation care |
162 |
151 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
237 |
179 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
132 |
109 |
$0.00 |
| 82077 |
|
13 |
12 |
$0.00 |
| 85027 |
|
16 |
14 |
$0.00 |
| 87205 |
|
29 |
26 |
$0.00 |
| 87486 |
|
20 |
18 |
$0.00 |
| 85651 |
|
13 |
12 |
$0.00 |
| 87280 |
|
14 |
14 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
17 |
12 |
$0.00 |
| 97597 |
|
36 |
12 |
$0.00 |